US commercial architecture for founders, CEOs, GMs, and US commercial heads at Tel Aviv-headquartered cyber, AI, medtech, biotech, and infrastructure firms. Delaware C-corps with a US office, US VC behind them, and a US revenue gap that does not match the team's caliber. Israeli technical novelty carried into US category leadership the enterprise procurement reader can act on.
The Delaware C-corp is in place. The Boston or Bay Area office is open. The US VC round closed in the last eighteen months. The US revenue gap is the conversation that keeps coming up at the board, with the team's caliber and the product quality both ahead of where the US numbers sit. The internal hypothesis becomes that the US team needs more SDRs, more outbound budget, and a sharper sales playbook. The US enterprise procurement data says otherwise.
The instinct is to scale the SDR team and spend more on outbound. The logic is clean. More accounts, more pipeline, more closes. The problem is that the SDR team is booking meetings inside a frame the US enterprise buyer cannot place inside their own category. The website leads with technology novelty. The deck opens with the founder's Unit 8200 background. The case studies are heavy on technical achievement and light on US enterprise outcomes. The pricing posture reads as venture-priced rather than enterprise-priced. The meetings happen. They do not convert.
US enterprise procurement readers filter on three signals at the gate: a US category they can place, a US peer set they recognise, and a US-procurement-grade risk architecture they can sign off on. Israeli founder culture builds confidence through technical novelty, founder-cohort lineage, and the velocity of the local ecosystem. Both registers are coherent. They do not translate. The Israeli novelty frame reads in the US as origin, not as commercial position. The work is to rebuild the US category anchor and the US peer-set positioning before the SDR team is scaled, so the meetings happen inside an architecture that produces enterprise procurement decisions.
The Israeli technical caliber is real. The novelty frame is doing work that US category leadership should be doing. That is the architectural fix. House view on Tel Aviv operator entry into the US
The company is not the problem. The founder is not the problem. The US-facing frame is, and the frame is fixable.
Six to ten weeks. Single US category, single corridor. The firm rebuilds positioning, pricing posture, messaging, and trust architecture for the US enterprise procurement reader, then launches it into market. Common first engagement when a single US category needs repositioning ahead of a funding round or a US enterprise sales push.
See the Sprint →Three to six months. Multi-channel US rebuild and run. Paid, owned, earned, conversion architecture, and sales enablement. The standard shape for Tel Aviv operators preparing to scale a US team, run an SDR organisation against US enterprise procurement readers, or rebuild the full US-facing surface ahead of a US round.
See the Build →Monthly retainer, twelve-month minimum. Ongoing rebuild-and-run across multiple US-facing surfaces. Typical for Tel Aviv operators running several US product lines, a public-market profile alongside enterprise sales, or post-acquisition integration into a US strategic.
See the Partnership →No legal services. No Delaware, Israeli entity, or US branch formation. No L-1, E-2, EB-5, or O-1 visa work. No US tax structuring, transfer-pricing analysis, or Israel-US double-taxation treaty review. No US banking introductions. No fiduciary services. No regulatory licensing, FDA submissions, AMAR conformity, or US securities work. No IP filing or patent prosecution. No contract drafting. No US recruiting or executive search. No M&A advisory.
These belong with Israeli counsel who specialise in US entry, with US counsel on the American side, and with regulatory consultants who handle FDA and clinical pathways. The firm works inside the parameters they set. When a marketing decision carries legal, tax, or regulatory implications, the firm flags it and defers before execution.
The Israeli unicorn frame is a category at home and a flag in the US. The US enterprise procurement reader sees Israeli origin, not US category position. The work is not to hide the origin, it is to stop letting origin do the work that US category leadership and US peer-set comparables should be doing. The home-market materials and the Hebrew-language press keep the Israeli framing in full. The US site, deck, outbound, and the founder's US-facing register are rebuilt to lead with the US category, the US peer set, and US-procurement risk architecture. The origin sits as background, not as the opening signal.
Cyber firms, including the Unit 8200 alumni founder cohort and operators trained at Check Point, CyberArk, and Palo Alto, AI and ML technical B2B platforms, medtech operators, biotech principals, and infrastructure firms in autonomous, sensor-fusion, and adjacent categories. Most Tel Aviv operators in scope already incorporate as Delaware C-corps and run US offices in Boston or the Bay Area. Fit is confirmed in discovery, not in published sector lists.
Yes. A US-VC-backed startup with a Boston or Bay Area office runs on a US round-cycle clock and needs a US category anchor that VCs and US enterprise buyers read in the same register. A Tel Aviv-listed operator running US revenue from Israel inherits investor materials and an analyst register that the US enterprise buyer reads differently than the public-market reader does. Both routes start from the same discovery conversation and produce different deliverables. Both still pivot on rebuilding the US category position before scaling US outbound.
Often it is the wrong first move. The SDR team inherits the frame the founder hands them. If the frame is novelty-led, founder-bio-heavy on Unit 8200 or Israeli technical heritage, light on US category leadership, and missing US peer-set comparables, the SDR team produces meetings that do not convert. The sequence that works is to rebuild the US category anchor and US peer-set positioning before the SDR team is scaled, so the meetings the team books happen inside an architecture that produces US enterprise procurement decisions.
With an inquiry through the contact form and a short discovery conversation. The firm runs three engagements: Market Entry Sprint (6 to 10 weeks), Cross-Border Build (3 to 6 months), or Group Partnership (monthly retainer, 12-month minimum). Fit and pricing are confirmed in discovery, not published. Tel Aviv operator engagements often begin as a Sprint when a single US category needs repositioning ahead of a funding round or a sales push, and as a Build when the full US-facing surface needs rebuilding before US team scale.
The wider Tel Aviv entry gate for principals, operators, and family offices moving into the United States.
See the Tel Aviv gate →House view on the Israeli cyber and medtech corridor into US enterprise. Why novelty needs to step aside for US category leadership.
Read the analysis →Three engagement shapes: Market Entry Sprint, Cross-Border Build, Group Partnership. Selection is by scope, not by sector.
See engagements →